These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 21426309

  • 21. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation.
    McMaster M, Zhou Y, Shorter S, Kapasi K, Geraghty D, Lim KH, Fisher S.
    J Immunol; 1998 Jun 15; 160(12):5922-8. PubMed ID: 9637505
    [Abstract] [Full Text] [Related]

  • 22. Maternal and fetal immune responses during pregnancy.
    Sargent IL.
    Exp Clin Immunogenet; 1993 Jun 15; 10(2):85-102. PubMed ID: 8251183
    [Abstract] [Full Text] [Related]

  • 23. Maternal/fetal interactions: the role of the MHC class I molecule HLA-G.
    Schmidt CM, Orr HT.
    Crit Rev Immunol; 1993 Jun 15; 13(3-4):207-24. PubMed ID: 8110376
    [Abstract] [Full Text] [Related]

  • 24. Urokinase plasminogen activator (uPA) and its receptor (uPAR) in gestational tissues; Measurements and clinical implications.
    Uszyński M, Perlik M, Uszyński W, Zekanowska E.
    Eur J Obstet Gynecol Reprod Biol; 2004 May 10; 114(1):54-8. PubMed ID: 15099871
    [Abstract] [Full Text] [Related]

  • 25. [Decreased alpha fetoprotein in maternal serum in relation to increased alpha fetoprotein in amniotic fluid in a case of fetal trisomy 21 associated with esophageal atresia].
    Gembruch U, Bellmann O, Hansmann M.
    Geburtshilfe Frauenheilkd; 1987 Aug 10; 47(8):569-71. PubMed ID: 2443419
    [Abstract] [Full Text] [Related]

  • 26. Elevation of macrophage colony-stimulating factor in amniotic fluid at late stage of normal pregnancy.
    Hayashi M, Hombo Y, Shibazaki M, Nakajima A, Inaba N.
    Am J Reprod Immunol; 2006 Mar 10; 55(3):226-31. PubMed ID: 16451357
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma.
    Tamaki S, Kawakami M, Ishitani A, Kawashima W, Kasuda S, Yamanaka Y, Shimomura H, Imai Y, Nakagawa Y, Hatake K, Kirita T.
    Anticancer Res; 2010 Oct 10; 30(10):4097-101. PubMed ID: 21036725
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases.
    Haumonte JB, Caillat-Zucman S, Bretelle F, Lambert M, Lyonnet L, Levy-Mozziconacci A, Farnarier C, Aubert A, Boubli L, Camoin-Jau L, Dignat George F, Paul P.
    Biomed Res Int; 2014 Oct 10; 2014():653161. PubMed ID: 25243172
    [Abstract] [Full Text] [Related]

  • 31. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
    Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE.
    Am J Obstet Gynecol; 2007 Sep 10; 197(3):255.e1-5. PubMed ID: 17826409
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.
    Jiang X, Huang JF, Huo Z, Zhang Q, Jiang Y, Wu X, Li Y, Jiang G, Zeng L, Yan XX, Yu P, Cao R.
    BMC Immunol; 2012 Nov 26; 13():62. PubMed ID: 23181907
    [Abstract] [Full Text] [Related]

  • 35. Soluble MHC I and soluble MIC molecules: potential therapeutic targets for cancer.
    Zhao J, Guo Y, Yan Z, Zhang J, Bushkin Y, Liang P.
    Int Rev Immunol; 2011 Feb 26; 30(1):35-43. PubMed ID: 21235324
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A-B-O(H) blood group substances in the human maternal-fetal barrier and amniotic fluid.
    FREDA VJ.
    Am J Obstet Gynecol; 1958 Aug 26; 76(2):407-16. PubMed ID: 13559330
    [No Abstract] [Full Text] [Related]

  • 38. [Immuno-chemical investigations on the problem of the "pregnancy zone". 3. Analysis of pregnancy-typical antigens].
    Hofmann R, Friemel H, Behm E, Brock J.
    Arch Gynakol; 1970 Mar 11; 208(3):255-65. PubMed ID: 4984157
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.